Press Releases Year None20232022202120202019 Aug 12, 2021 Century Therapeutics Reports Second Quarter 2021 Financial Results and Business Updates Jun 22, 2021 Century Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares Jun 17, 2021 Century Therapeutics Announces Pricing of Initial Public Offering Jun 01, 2021 Century Therapeutics Adds Respected Biotech Executives to Board of Directors May 05, 2021 Century Therapeutics Expands Board of Directors with Key Appointments Mar 03, 2021 Century Therapeutics Completes $160 Million Series C Financing to Accelerate Development of iPSC-derived Cell Therapy Pipeline Feb 17, 2021 Century Therapeutics Significantly Expands Capabilities with New Operational, Laboratory and Manufacturing Facilities in Pennsylvania and New Jersey Sep 16, 2020 Century Therapeutics Announces Appointment of Michael C. Diem as Chief Business Officer Jun 23, 2020 Century Therapeutics Announces Acquisition of Empirica Therapeutics May 05, 2020 Century Therapeutics Announces Formation of Scientific Advisory Board First page « Previous page ‹ Page 1 Page 2 Page 3 Page 4 Current page 5 Page 6 Next page › Last page » Displaying 41 - 50 of 53
